A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study)

NCT03842267 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

315

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: Gemigliptin 50mg
DRUG: Gemigliptin Placebo

Sponsor

LG Chem